Association between Alzheimer's Disease and Oral and Gut Microbiota: Are Pore Forming Proteins the Missing Link?
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing theoretical mechanisms without original empirical data or systematic review methodology.
PubMed 30040725 · doi:10.3233/JAD-180319
What was done
This narrative review synthesized literature on potential associations between bacterial infections—specifically involving oral biofilms and gut microbiota—and Alzheimer's disease (AD). The authors examined potential mechanisms including pore-forming bacterial proteins, transport of bacterial toxins and porins to the brain via outer membrane vesicles, and the role of amyloid-beta as an antimicrobial peptide.
What was found
The abstract presents a theoretical framework and reports no numerical or quantitative findings. The authors note that amyloid-beta displays antimicrobial activity against various bacteria and propose that its upregulation in the brain could occur in response to bacterial invasion and toxin delivery.
Why it matters
The paper outlines a mechanistic hypothesis connecting oral and gastrointestinal dysbiosis to AD neuropathology, highlighting biofilm control as a potential preventive target to investigate.
Limits
This is a non-systematic narrative review providing theoretical mechanisms without novel human or experimental data. No sample sizes, effect estimates, or statistical data are reported, and causality between bacterial pathogens and human AD remains unproven.
Cited by
- supports Amyloid aggregates have been shown in laboratory studies to create holes in bacterial cell membranes, leading to the hypothesis that amyloid functions as an antibacterial protein.